OCUL
OCUL
NASDAQ · Pharmaceuticals

Ocular Therapeutix Inc

$9.43
-0.21 (-2.18%)
As of Jun 21, 10:04 PM ET ·
Analyst Consensus
Strong Buy
18
Analysts
High
Coverage
Buy 17 94%
Hold 1 6%
Sell 0 0%
Price Target
Analyst Price Target +501.3% upside
Low Target $44.23
Average Target $56.70
High Target $95.28
Current Price $9.43
Current
$9.43
Target
$56.70
$44.23 $56.70 avg $95.28
Scenario Analysis
Bear Case
$44.23
369.0%
Low target
Base Case
$56.70
+501.3%
Avg target
Bull Case
$95.28
+910.4%
High target
Risk/Reward
2.5x
Favorable
Price in Context
52-Week High
$16.44
-42.6% from high
52-Week Low
$6.23
+51.4% from low
Target vs 52W High
$56.70
+244.9% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +19.4%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +24.7%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +31.4%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +40.7%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +214.2%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +168.5%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -34.5%